Calcitonin is a naturally occurring calciotropic hormone which plays a
n important physiologic role in mineral and skeletal homeostasis. The
salmon species of calcitonin (SCT) is currently being used therapeutic
ally in pharmacologic doses for the treatment of skeletal conditions i
n which there is a component of excessive bone resorption, including o
steoporosis, Paget's disease, malignant hypercalcemia, Sudeck's atroph
y, familial hyperphosphatasemia, osteogenesis imperfecta, renal osteod
ystrophy, and painful bony metastases. A consideration of the effects
of SCT on animal and human skeletal integrity and bone quality permits
further insight into the spectrum of calcitonin effects. The studies
reviewed herein have investigated the effects of calcitonin on paramet
ers indicative of bone quality, including quantitative effects on bone
mass, histomorphometric assessment of skeletal architecture, mechanic
al properties, ultrasound parameters, and fracture incidence. In addit
ion, relevant data from in vivo and in vitro studies of the anabolic e
ffects of calcitonin are also reviewed as an osteoblastic action of ca
lcitonin may have clinical relevance.